Abstract
DNA double-strand breaks (DSBs) are a common form of DNA damage and double-strand break rejoining is a fundamental mechanism of genome protection to prevent chromosomal fragmentation, translocation and deletions. DSBs may be induced by exogenous agents, such as ionizing radiation, but also occur spontaneously during cellular processes e.g. in the rearrangement of gene segments during V(D)J [variable (V), diversity (D), joining (J)] recombination. The ge-nomic instability resulting from incorrectly repaired DSBs can lead to carcinogenesis, while unrepaired may carry on even to cell death. To repair this potentially lethal damage cells developed several different types of repair act on the DSBs e.g. homologous recombination repair (HRR), non-homologous DNA end joining (NHEJ), and single-strand annealing (SSA).The most essential in mammalian cells is NHEJ, whereas HRR and SSA significantly contributes to DSBs repair in lower eukaryotes. At least six distinct proteins are known to be required for NHEJ, i ncluding Ku70, Ku80, DNA-PKcs, XRCC4, DNA ligase IV, and Artemis. In this review we highlight classical and up-to-date aspects and present understanding of the molecular mechanisms of NHEJ in the maintenance of genome integrity.
Keywords: Non-homologous DNA end joining, NHEJ, DNA double-strand breaks repair, DNA-PK, DNA-PKcs, Ku70, Ku80, XRCC4, ligase IV, Artemis
Current Genomics
Title: Double-Strand Breaks Repair by Non-Homologous DNA End Joining in Mammalian Cells
Volume: 7 Issue: 5
Author(s): Mariusz Malinowski and Elzbieta Pastwa
Affiliation:
Keywords: Non-homologous DNA end joining, NHEJ, DNA double-strand breaks repair, DNA-PK, DNA-PKcs, Ku70, Ku80, XRCC4, ligase IV, Artemis
Abstract: DNA double-strand breaks (DSBs) are a common form of DNA damage and double-strand break rejoining is a fundamental mechanism of genome protection to prevent chromosomal fragmentation, translocation and deletions. DSBs may be induced by exogenous agents, such as ionizing radiation, but also occur spontaneously during cellular processes e.g. in the rearrangement of gene segments during V(D)J [variable (V), diversity (D), joining (J)] recombination. The ge-nomic instability resulting from incorrectly repaired DSBs can lead to carcinogenesis, while unrepaired may carry on even to cell death. To repair this potentially lethal damage cells developed several different types of repair act on the DSBs e.g. homologous recombination repair (HRR), non-homologous DNA end joining (NHEJ), and single-strand annealing (SSA).The most essential in mammalian cells is NHEJ, whereas HRR and SSA significantly contributes to DSBs repair in lower eukaryotes. At least six distinct proteins are known to be required for NHEJ, i ncluding Ku70, Ku80, DNA-PKcs, XRCC4, DNA ligase IV, and Artemis. In this review we highlight classical and up-to-date aspects and present understanding of the molecular mechanisms of NHEJ in the maintenance of genome integrity.
Export Options
About this article
Cite this article as:
Malinowski Mariusz and Pastwa Elzbieta, Double-Strand Breaks Repair by Non-Homologous DNA End Joining in Mammalian Cells, Current Genomics 2006; 7 (5) . https://dx.doi.org/10.2174/138920206778604386
DOI https://dx.doi.org/10.2174/138920206778604386 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Advanced Computational Algorithms and Artificial Intelligence in Clinical Pharmacogenomics
In the era of personalized medicine, understanding the relationship between genetics and drug response is crucial. This issue delves into innovative methodologies, leveraging deep computational analysis and artificial intelligence, to enhance the field of Clinical Pharmacogenomics. The interdisciplinary approach harnesses the power of advanced high-throughput genotyping technologies, sophisticated computational analysis, ...read more
Applications of Single-cell Sequencing Technology in Reproductive Medicine
Single cell sequencing (SCS) technology utilizes individual cells' genetic material to sequence their genome, transcriptome, and epigenetics at the molecular level. It offers insights into cell heterogeneity and enables the study of limited biological materials. Since its recognition as a valuable technique in 2011, single cell sequencing has yielded numerous ...read more
Big Data in Cancer Research
Cancer is a significant threat to human life and health, remaining a highly aggressive killer. It is a leading cause of death worldwide and represents a crucial medical issue for humanity. However, in the past decade, the effectiveness of new synthetic anticancer agents has not matched the current clinical speculation. ...read more
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Medicinal Chemistry of Nitrite as a Source of Nitric Oxide Signaling
Current Topics in Medicinal Chemistry Histone Deacetylase Inhibitors: Recent Insights from Basic to Clinical Knowledge & Patenting of Anti-Cancer Actions
Recent Patents on Anti-Cancer Drug Discovery Bariatric Surgery: Indications, Safety and Efficacy
Current Pharmaceutical Design Use of Cell Lines in the Investigation of Pharmacogenetic Loci
Current Pharmaceutical Design Ontologies of Drug Discovery and Design for Neurology, Cardiology and Oncology
Current Pharmaceutical Design Recent Development in Indole Derivatives as Anticancer Agent: A Mechanistic Approach
Anti-Cancer Agents in Medicinal Chemistry ACE2-Ang-(1-7)-Mas Axis in Brain: A Potential Target for Prevention and Treatment of Ischemic Stroke
Current Neuropharmacology Mechanism(s) Involved in Opioid Drug Abuse Modulation of HAND
Current HIV Research Advances in Chemotherapy and Targeted Systemic Therapies for Urothelial Cancer
Current Drug Therapy Targeting Opioid and Neurokinin-1 Receptors to Treat Alcoholism
Current Medicinal Chemistry Understanding the Interaction Between Human Serum Albumin and Anti-Bacterial/ Anti-Cancer Compounds
Current Pharmaceutical Design In Silico Analysis and Molecular Docking Studies of Novel 6,7-dihydropyrano [2,3-d] pyrimidin-5-one Derivatives as Human Epidermal Growth Factor Receptor 2 (HER2) and Epidermal Growth Factor Receptor (EGFR) Inhibitors
Current Cancer Therapy Reviews Immune Receptors, Cadherins and their Interactions
Current Immunology Reviews (Discontinued) How Does Indoleamine 2,3-Dioxygenase Contribute to HIV-Mediated Immune Dysregulation
Current Drug Metabolism Nanomedical Platform for Drug Delivery in Cancer
Current Organic Chemistry Cellular Functions of Vaults and their Involvement in Multidrug Resistance
Current Drug Targets Inhibition of V-ATPase and Carbonic Anhydrases as Interference Strategy with Tumor Acidification Processes
Current Pharmaceutical Design Irreversible Inhibition of Serine Proteases – Design and In Vivo Activity of Diaryl α-Aminophosphonate Derivatives
Current Medicinal Chemistry Development of Novel Therapeutics Targeting the Urokinase Plasminogen Activator Receptor (uPAR) and Their Translation Toward the Clinic
Current Pharmaceutical Design Severe Adenovirus Pneumonia Followed by Bacterial Septicaemia: Relevance of Co-Infections in Allogeneic Hematopoietic Stem Cell Transplantation
Infectious Disorders - Drug Targets